![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Daiichi Fine Chemical Co., Ltd. Takaoka Jp, based in Japan, is a pharmaceutical company that stands out with its certifications from FDA.
One of their significant offerings is Dexpanthenol, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2006-108 - Rev 00
This Chemical Type CEP, issued on February 18, 2013, remains in force until December 15, 2020, ensuring its reliability within the pharmaceutical industry.
Substance Number 761 associated with this CEP further emphasizes